Name | N-Methyl-1-(5-methyl-1,3-thiazol-2-yl)methanamine dihydrochloride |
---|---|
Synonyms |
methyl[(2-methyl-1,3-oxazol-4-yl)methyl]amine
N-methyl-1-(2-methyloxazol-4-yl)methanamine N-methyl-1-(5-methylthiazol-2-yl)methanamine 2-Methyl-4-[(methylamino)methyl]-1,3-oxazole |
Molecular Formula | C6H12Cl2N2S |
---|---|
Molecular Weight | 215.14400 |
Exact Mass | 214.01000 |
PSA | 53.16000 |
LogP | 3.16580 |
HS Code | 2934100090 |
---|
~82% 921145-14-4 |
Literature: COMENTIS, INC.; PURDUE RESEARCH FOUNDATION Patent: WO2009/42694 A1, 2009 ; Location in patent: Page/Page column 85-86 ; WO 2009/042694 A1 |
~% 921145-14-4 |
Literature: COMENTIS, INC.; ASTELLAS PHARMA INC.; BILCER, Geoffrey, M.; DEVASAMUDRAM, Thippeswamy; LILLY, John, C.; ANKALA, Sudha, V.; MOSKALEV, Nikolai, V.; LIU, Chunfeng; INOUE, Makoto; KAWAKAMI, Shimpei; MUNAKATA, Ryosuke; HAMAJIMA, Toshihiro Patent: WO2012/54510 A1, 2012 ; Location in patent: Page/Page column 86 ; WO 2012/054510 A1 |
HS Code | 2934100090 |
---|---|
Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |